{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:32:43Z","timestamp":1760549563816},"reference-count":41,"publisher":"Cambridge University Press (CUP)","issue":"7","license":[{"start":{"date-parts":[[2014,7,7]],"date-time":"2014-07-07T00:00:00Z","timestamp":1404691200000},"content-version":"unspecified","delay-in-days":6,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Laryngol. Otol."],"published-print":{"date-parts":[[2014,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S0022215114001157_sec1\"><jats:title>Objective:<\/jats:title><jats:p>We aimed to evaluate the clinical efficacy of ciprofloxacin plus fluocinolone acetonide (antibiotic plus corticosteroid) ear drops compared to ciprofloxacin (antibiotic) ear drops in diffuse otitis externa.<\/jats:p><\/jats:sec><jats:sec id=\"S0022215114001157_sec2\"><jats:title>Methods:<\/jats:title><jats:p>This was a multicentre, randomised, parallel-group, double-blind study involving 590 patients of both sexes aged 7\u00a0years or older.<\/jats:p><\/jats:sec><jats:sec id=\"S0022215114001157_sec3\"><jats:title>Results:<\/jats:title><jats:p>The rate of clinical cure was higher (<jats:italic>p<\/jats:italic>\u00a0=\u00a00.01) with ciprofloxacin plus fluocinolone acetonide than with ciprofloxacin alone. The mean total symptom score was lower with ciprofloxacin plus fluocinolone acetonide (<jats:italic>p<\/jats:italic>\u00a0=\u00a00.005). No differences were found in the percentage of patients reporting resolution of otalgia between patients receiving ciprofloxacin plus fluocinolone acetonide and patients receiving only ciprofloxacin. Resolution of oedema and otorrhoea (<jats:italic>p<\/jats:italic>\u00a0=\u00a00.003 and <jats:italic>p<\/jats:italic>\u00a0=\u00a00.002, respectively) was higher with ciprofloxacin plus fluocinolone acetonide, as was eradication or presumed eradication (<jats:italic>p<\/jats:italic>\u00a0=\u00a00.003). There were eight mild adverse events, three with the ciprofloxacin plus fluocinolone acetonide combination (not related to the treatment) and five when ciprofloxacin was administered alone (directly related to the treatment).<\/jats:p><\/jats:sec><jats:sec id=\"S0022215114001157_sec4\"><jats:title>Conclusions:<\/jats:title><jats:p>Ciprofloxacin plus fluocinolone acetonide is a more effective treatment for diffuse otitis externa than ciprofloxacin alone. The ciprofloxacin plus fluocinolone acetonide combination also has an excellent safety profile.<\/jats:p><\/jats:sec>","DOI":"10.1017\/s0022215114001157","type":"journal-article","created":{"date-parts":[[2014,7,7]],"date-time":"2014-07-07T08:42:19Z","timestamp":1404722539000},"page":"591-598","source":"Crossref","is-referenced-by-count":8,"title":["Ciprofloxacin plus fluocinolone acetonide versus ciprofloxacin alone in the treatment of diffuse otitis externa"],"prefix":"10.1017","volume":"128","author":[{"given":"J","family":"Lorente","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Sabater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M P","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Fuste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Risco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2014,7,7]]},"reference":[{"key":"S0022215114001157_ref24","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1992.01880080064014"},{"key":"S0022215114001157_ref22","first-page":"28","article-title":"Does ciprofloxacin affect inner ear? A preliminary report","volume":"60","author":"Bagger-Sj\u00f6b\u00e4ck","year":"1989","journal-title":"Scand J Infect Dis Suppl"},{"key":"S0022215114001157_ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1979.03290310027008"},{"key":"S0022215114001157_ref23","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1990.01870050057006"},{"key":"S0022215114001157_ref13","first-page":"250","article-title":"Use of ciprofloxacin in chronic suppurative otitis","volume":"10","author":"Van de Heyning","year":"1988","journal-title":"Rev Infect Dis"},{"key":"S0022215114001157_ref9","doi-asserted-by":"publisher","DOI":"10.1288\/00005537-198905000-00009"},{"key":"S0022215114001157_ref17","doi-asserted-by":"publisher","DOI":"10.3109\/00016487809124726"},{"key":"S0022215114001157_ref4","first-page":"1","article-title":"Aminoglycoside-induced cochlear pathology in man","volume":"383","author":"Johnsson","year":"1981","journal-title":"Acta Otolaryngol Suppl"},{"key":"S0022215114001157_ref12","first-page":"399","volume-title":"First International Ciprofloxacin Workshop. Leverkusen, 6\u20138 November 1985. Current Clinical Practice Series","author":"Federspil","year":"1986"},{"key":"S0022215114001157_ref26","first-page":"217","article-title":"Prospective double-blind randomized study of the efficacy and tolerance of topical ciprofloxacin vs topical gentamicin in the treatment of simple chronic otitis media and diffuse external otitis [in Spanish]","volume":"47","author":"Sabater","year":"1996","journal-title":"Acta Otorrinolaringol Esp"},{"key":"S0022215114001157_ref6","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1988.01860190059023"},{"key":"S0022215114001157_ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1978.tb13212.x"},{"key":"S0022215114001157_ref11","first-page":"397","volume-title":"First International Ciprofloxacin Workshop. Leverkusen, 6\u20138 November 1985. Current Clinical Practice Series","author":"Falser","year":"1986"},{"key":"S0022215114001157_ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2273.1990.tb00425.x"},{"key":"S0022215114001157_ref20","doi-asserted-by":"publisher","DOI":"10.1159\/000278933"},{"key":"S0022215114001157_ref2","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215100108011"},{"key":"S0022215114001157_ref10","doi-asserted-by":"publisher","DOI":"10.1007\/BF01650508"},{"key":"S0022215114001157_ref15","first-page":"357","article-title":"Risk of deafness following ototopical administration of aminoglycoside antibiotic [in French]","volume":"35","author":"Dumas","year":"1980","journal-title":"Th\u00e9rapie"},{"key":"S0022215114001157_ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(05)80004-0"},{"key":"S0022215114001157_ref27","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1995.01890080048009"},{"key":"S0022215114001157_ref28","unstructured":"Center for Drug Evaluation and Research. New Drug Application 20-805. In: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/98\/20805-mr.pdf [3 June 2014]"},{"key":"S0022215114001157_ref5","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215100105444"},{"key":"S0022215114001157_ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2006.02.014"},{"key":"S0022215114001157_ref1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/31.3.452"},{"key":"S0022215114001157_ref33","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2273.1997.00857.x"},{"key":"S0022215114001157_ref29","unstructured":"European Medicines Agency. ICH topic E 6 (R1). Guideline for Good Clinical Practice. In: http:\/\/ethikkommission.meduniwien.ac.at\/fileadmin\/ethik\/media\/dokumente\/rechtsgrundlagen\/GCP.pdf [3 June 2014]"},{"key":"S0022215114001157_ref31","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1185\/03007999309111548","article-title":"Otitis externa: clinical comparison of local ciprofloxacin versus local oxytetracycline, polymyxin B, hydrocortisone combination treatment","volume":"13","author":"Arnes","year":"1993","journal-title":"Curr Med Res Opin"},{"key":"S0022215114001157_ref32","first-page":"386","article-title":"Local antibiotic therapy of bacterial ear infections [in German]","volume":"37","author":"Ganz","year":"1989","journal-title":"HNO"},{"key":"S0022215114001157_ref34","doi-asserted-by":"publisher","DOI":"10.1185\/03007990802603072"},{"key":"S0022215114001157_ref35","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31818b0c9c"},{"key":"S0022215114001157_ref36","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-6519(03)78439-8"},{"key":"S0022215114001157_ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2006.02.013"},{"key":"S0022215114001157_ref40","doi-asserted-by":"publisher","DOI":"10.1185\/030079902125004312"},{"key":"S0022215114001157_ref41","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S6769"},{"key":"S0022215114001157_ref16","doi-asserted-by":"publisher","DOI":"10.1288\/00005537-198604000-00017"},{"key":"S0022215114001157_ref14","first-page":"63","article-title":"Ciprofloxacin in oral treatment of ear infections","volume":"8","author":"Van de Heyning","year":"1986","journal-title":"Pharm Weekbl Sci"},{"key":"S0022215114001157_ref37","doi-asserted-by":"publisher","DOI":"10.1053\/ajot.2002.123461"},{"key":"S0022215114001157_ref21","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1992.01880040050009"},{"key":"S0022215114001157_ref25","first-page":"521","article-title":"Multicenter study comparing the efficacy and tolerability of topical ciprofloxacin (0.3%) versus topical gentamicin (0.3%) in the treatment of simple, non-cholesteatomatous chronic otitis media in the suppurative phase [in Spanish]","volume":"5","author":"Lorente","year":"1995","journal-title":"An Otorrinolaringol Ibero Am"},{"key":"S0022215114001157_ref8","first-page":"395","volume-title":"First International Ciprofloxacin Workshop. Leverkusen, 6\u20138 November 1985. Current Clinical Practice Series","author":"Ganz","year":"1986"},{"key":"S0022215114001157_ref19","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.5.1014"}],"container-title":["The Journal of Laryngology &amp; Otology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0022215114001157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T23:06:13Z","timestamp":1555887973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0022215114001157\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0022215114001157"],"URL":"https:\/\/doi.org\/10.1017\/s0022215114001157","relation":{},"ISSN":["0022-2151","1748-5460"],"issn-type":[{"value":"0022-2151","type":"print"},{"value":"1748-5460","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}